| Part Of Washington Journal 02/23/2018
Washington Journal
Report Video IssueWashington Journal
Starlee Coleman on Experimental "Right to Try" Movement
2018-02-23T08:05:51-05:00https://ximage.c-spanvideo.org/eyJidWNrZXQiOiJwaWN0dXJlcy5jLXNwYW52aWRlby5vcmciLCJrZXkiOiJGaWxlc1wvMWEzXC8yMDE4MDIyMzA4MDg0MTAwMV9oZC5qcGciLCJlZGl0cyI6eyJyZXNpemUiOnsiZml0IjoiY292ZXIiLCJoZWlnaHQiOjUwNn19fQ==Starlee Coleman talked about “right to try” medications that would allow terminally ill patients to obtain experimental drugs not approved by Food and Drug Administration.
Starlee Coleman talked about “right to try” medications that would allow terminally ill patients to obtain experimental drugs not approved by Food and Drug Administration.
Starlee Coleman talked about “right to try” medications that would allow terminally ill patients to obtain experimental drugs not approved by Food and Drug Administration.
People in this video
- Greta Brawner Host C-SPAN
-
Hosting Organization
Series
More Videos From
Washington Journal 02/23/2018
- Starlee Coleman on Experimental "Right to Try" Movement
- Open Phones, Part 2
- Tim Huelskamp on Economic and Energy Policy
- Becky Pringle on School Safety
Purchase a Download
Starlee Coleman on Experimental "Right to Try" Movement
-
MP4 video - Standard
- Price:
- $4.99
-
MP3 audio - Standard
- Price:
- $0.99
Related Video
-
Lev Facher on Bipartisan Opioid Legislation
Lev Facher talked about the bipartisan push for legislation to help curb the opioid crisis.
-
David Mitchell on Prescription Drug Costs
David Mitchell talked about efforts by his Patients For Affordable Drugs organization to lower prescription drug prices.
-
Debate on Experimental Drugs for the Terminally Ill
Members debated a “Right-to-Try” bill, a measure allowing terminally ill patients to try experimental drugs not yet appr…
-
House Debate on Experimental Drugs and Terminally Ill
The House debated a bill that allows terminally ill patients to try experimental drugs without full FDA approval. The me…
User Created Clips from This Video
-
- 25 seconds
- 10 views